These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 34461201)

  • 1. Rationally designed drug delivery systems for the local treatment of resected glioblastoma.
    Bastiancich C; Malfanti A; Préat V; Rahman R
    Adv Drug Deliv Rev; 2021 Oct; 177():113951. PubMed ID: 34461201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer drug-loaded hydrogels as drug delivery systems for the local treatment of glioblastoma.
    Bastiancich C; Danhier P; Préat V; Danhier F
    J Control Release; 2016 Dec; 243():29-42. PubMed ID: 27693428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection.
    Bastiancich C; Bianco J; Vanvarenberg K; Ucakar B; Joudiou N; Gallez B; Bastiat G; Lagarce F; Préat V; Danhier F
    J Control Release; 2017 Oct; 264():45-54. PubMed ID: 28830791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local delivery to malignant brain tumors: potential biomaterial-based therapeutic/adjuvant strategies.
    Alghamdi M; Gumbleton M; Newland B
    Biomater Sci; 2021 Sep; 9(18):6037-6051. PubMed ID: 34357362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival.
    Zhao M; Danhier F; Bastiancich C; Joudiou N; Ganipineni LP; Tsakiris N; Gallez B; Rieux AD; Jankovski A; Bianco J; Préat V
    Int J Pharm; 2018 Sep; 548(1):522-529. PubMed ID: 30017818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection.
    Graham-Gurysh E; Moore KM; Satterlee AB; Sheets KT; Lin FC; Bachelder EM; Miller CR; Hingtgen SD; Ainslie KM
    Mol Pharm; 2018 Mar; 15(3):1309-1318. PubMed ID: 29342360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment.
    Ganipineni LP; Danhier F; Préat V
    J Control Release; 2018 Jul; 281():42-57. PubMed ID: 29753958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials.
    Bruinsmann FA; Richter Vaz G; de Cristo Soares Alves A; Aguirre T; Raffin Pohlmann A; Stanisçuaski Guterres S; Sonvico F
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31779126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Delivery Nanosystems in Glioblastoma Multiforme Treatment: Current State of the Art.
    Di Filippo LD; Duarte JL; Luiz MT; de Araújo JTC; Chorilli M
    Curr Neuropharmacol; 2021; 19(6):787-812. PubMed ID: 32867643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing Next-Generation Local Drug Delivery Vehicles for Glioblastoma Adjuvant Chemotherapy: Lessons from the Clinic.
    Tabet A; Jensen MP; Parkins CC; Patil PG; Watts C; Scherman OA
    Adv Healthc Mater; 2019 Feb; 8(3):e1801391. PubMed ID: 30632715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery-A Comprehensive Review of the Literature.
    Alomari S; Zhang I; Hernandez A; Kraft CY; Raj D; Kedda J; Tyler B
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in drug delivery technology for the treatment of glioblastoma multiforme.
    Cha GD; Kang T; Baik S; Kim D; Choi SH; Hyeon T; Kim DH
    J Control Release; 2020 Dec; 328():350-367. PubMed ID: 32896613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of Therapies for Glioblastoma (GBM) Using Nanoparticle-based Delivery Systems.
    Wiwatchaitawee K; Quarterman JC; Geary SM; Salem AK
    AAPS PharmSciTech; 2021 Feb; 22(2):71. PubMed ID: 33575970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Vascular Drug Delivery in Cerebral Cancer.
    Humle N; Johnsen KB; Arendt GA; Nielsen RP; Moos T; Thomsen LB
    Curr Pharm Des; 2016; 22(35):5487-5504. PubMed ID: 27464719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harnessing nanomedicine for therapeutic intervention in glioblastoma.
    Gutkin A; Cohen ZR; Peer D
    Expert Opin Drug Deliv; 2016 Nov; 13(11):1573-1582. PubMed ID: 27292970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-ligand functionalized blood-to-tumor sequential targeting strategies in the field of glioblastoma nanomedicine.
    Martins C; Sarmento B
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1893. PubMed ID: 37186374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Near Infrared Fluorescent Nanoplatform for Targeted Intraoperative Resection and Chemotherapeutic Treatment of Glioblastoma.
    Reichel D; Sagong B; Teh J; Zhang Y; Wagner S; Wang H; Chung LWK; Butte P; Black KL; Yu JS; Perez JM
    ACS Nano; 2020 Jul; 14(7):8392-8408. PubMed ID: 32551496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
    Wang D; Wang C; Wang L; Chen Y
    Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontiers in the treatment of glioblastoma: Past, present and emerging.
    Janjua TI; Rewatkar P; Ahmed-Cox A; Saeed I; Mansfeld FM; Kulshreshtha R; Kumeria T; Ziegler DS; Kavallaris M; Mazzieri R; Popat A
    Adv Drug Deliv Rev; 2021 Apr; 171():108-138. PubMed ID: 33486006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.